Table: RaQualia Pharma - 9-MTH group results

RaQualia Pharma

13/11/2020 06:01

Nov 13 (Reuters)- 
             RaQualia Pharma Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended        Year to  
                Sep 30, 2020        Sep 30, 2019      Dec 31, 2020  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales            573 mln             708 mln            1.58      
                 (-19.0 pct)         (+32.9 pct)       (-7.2 pct)   
  Operating     loss 600 mln        loss 534 mln      loss 260 mln  
  Recurring     loss 615 mln        loss 527 mln      loss 256 mln  
  Net           loss 698 mln        loss 531 mln      loss 333 mln  
  EPS          loss 33.35 yen      loss 25.94 yen    loss 15.93 yen 
  Ann Div                                NIL               NIL      
  -Q2 div            NIL                 NIL                        
  -Q4 div                                NIL               NIL      
  
  NOTE - RaQualia Pharma Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4579.T